Analytical Bio-Chemistry Laboratories to Develop Liprostin Assays for Endovasc's Phase III Trial HOUSTON, June 27, 2006 (PRIMEZONE) -- Endovasc, Inc. (OTCBB:EVSC) today announced that the Company has awarded Analytical Bio-Chemistry Laboratories, Inc. a contract to develop an assay to determine...